中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)3162941.622318808.191576119.36720561.112798460.53
营业收入(万元)3162941.622318808.191576119.36720561.112798460.53
营业总成本(万元)2320389.331694966.541089980.16512854.182101154.14
营业成本(万元)436265.58319544.12211496.22106866.25384817.74
净利润(万元)772204.70577085.74447655.04187650.22633417.49
归属于母公司的净利润(万元)771105.48575116.95445010.64187405.55633652.70
营业利润(万元)899000.28662451.24515889.27208598.09749063.20
利润总额(万元)870762.55641200.78505093.42207560.37716969.00
少数股东损益(万元)594.74906.56456.43238.6446.76
基本每股收益(元)1.19(元)0.89(元)0.70(元)0.30(元)1.00(元)
稀释每股收益(元)1.18(元)0.89(元)0.70(元)0.30(元)1.00(元)
非经常性损益(万元)29764.9216181.98--1076.8915856.05
扣除非经常性损益后净利润(万元)741340.56558934.97427284.85186328.66617796.65
总资产(万元)6986731.586832754.056289351.715129278.175013564.53
总负债(万元)807049.24829502.25386371.91374301.26404539.46
归属于母公司股东权益合计(万元)6127206.865950425.085846483.124698705.954551986.19
股东权益合计(万元)6179682.346003251.805902979.804754976.914609025.07
实收资本(股本)(万元)663719.99663719.99663719.99637900.23637900.23
资本公积(万元)1293461.631293203.731287149.67285387.48318807.26
未分配利润(万元)4017335.483834256.843704150.523573958.453386552.90
经营活动产生的现金流量净额(万元)1123537.81911043.03430045.3355517.41742275.30
经营活动现金流入小计(万元)3483415.992697282.281612379.40630193.652846888.17
经营活动现金流出小计(万元)2359878.181786239.251182334.08574676.242104612.87
投资活动产生的现金流量净额(万元)-274050.24-152626.69-108473.29-53167.76-191198.57
投资活动现金流入小计(万元)22140.3918819.5618283.2017035.4367989.22
投资活动现金流出小计(万元)296190.63171446.25126756.4970203.19259187.79
筹资活动产生的现金流量净额(万元)778170.74809102.04803949.50-66105.92-155059.00
筹资活动现金流入小计(万元)1226567.911078027.321035193.79--79990.94
筹资活动现金流出小计(万元)448397.17268925.28231244.2966105.92235049.94
期末现金及现金等价物余额(万元)4015555.273976770.813554260.512363116.362423910.21
最后修改日期2026-03-272025-10-282025-08-212025-04-252025-03-31
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。